We’re a next-generation liquid biopsy company.
Our mission is to enable a world where cancer can be detected early, diagnosed accurately, managed precisely, and ultimately cured.
The oncRNA technology began in the laboratories of the University of California, San Francisco.
Dr. Hani Goodarzi and Dr. Lisa Fish discovered the potential of identifying cancer-specific oncRNAs. By looking where others in the field had not, they discovered new biomarkers that will pave the way to changing the future of diagnostics.
Now, we are the veterans in the field.
Exai brings together intrepid leaders in the fields of RNA biology, liquid biopsy, and artificial intelligence who are joining forces to fulfill our vision.
Academics & Industry Experience
The vision and the means to act on it.
We plan to change the future of early cancer detection by providing clinical insights into cancer biology. And that future looks a lot brighter.
It requires a lot of hard work and collaboration. Does that excite you?
